Blood-derived DNA methylation markers of cancer risk. Advances in experimental medicine and biology 754, 233-252, doi: 10.1007/978-1-4419-9967-2_12 (2013).Marsit C, Christensen B. Blood-derived DNA methylation markers of cancer risk. Adv Exp Med Biol. 2013; 754:233-252. [PubMed: ...
Duration of work under exposure significantly influenced TPA and TPS concentrations in these models. All the metals examined were found to have influence on the concentration of cancer markers, except for CYFRA 21-1, but the direction of this influence varied. Lead (especially FEP level) and ...
(2). These ulcers significantly impair an eminence of life and increase healthcare expenditures for millions of people around the world. Over $25 billion is spent yearly in the United States alone on treatment of chronic wounds (3). Surgical debridement is the ma...
Integration of clinical, pathological, radiological, and transcriptomic data improves prediction for first-line immunotherapy outcome in metastatic non-small cell lung cancer Overall survival in metastatic non-small cell lung cancer is improved by immunotherapy but individual responses widely vary, and pre...
that the presence of allergy markers was, for example, associated with a decreased risk of colorectal cancer, pancreatic cancer, and larynx cancer, but with increased risks of lymphoma, prostate cancer, and myeloma, and there are inconsistent results for breast cancer and lung cancer [6, 8, 9...
Abstract A130: Metastatic melanoma patients responding to PD1 therapy have higher proportion of peripheral blood NKT-cells Anti-PD1 therapy has proven to be effective in various cancer types, but not all patients benefit from the therapy. Further, no comprehensive immunologic m... HHE Hakanen,M H...
Additionally, we assessed exposure levels of ultrafine particles (UFPs) in the breathing zone for specific job functions. As biomarkers of effect, we assessed lung function, plasma levels of acute phase inflammatory markers, and genetic damage levels in peripheral blood cells. Exposure levels of ...
Methylated DNA markers (MDMs) accurately identify several different cancer types, but there are limited data for pancreatic neuroendocrine tumors (pNETs). We aimed to identify MDM candidates in tissue that differentiate pNETs from normal pancreas. Methods wUsing DNA from frozen normal pancreas (13...
we did not have enough corresponding data for the UKB dataset. For CMI determination, we followed61and selected the top 11 morbidities strongly associated with age after the age of 40. The list of health conditions included cancer (any kind), cardiovascular conditions (angina pectoris, coronary ...
DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells. Cancer Res. 61, 1659–1665 (2001). CAS PubMed Google Scholar Silva, J. M. et al. Presence of tumor DNA in plasma of breast cancer patients: ...